Experts from across The Conversation look at how COVID-19 vaccines will work, how they're being tested and manufactured, and what challenges there will be to rolling them out.
Both Moderna and AstraZeneca have used cutting-edge designs to reduce their vaccines' development time.
The dangers of poor disclosure.
With Donald Trump already doing a great job of making the public more wary of a coronavirus vaccine, big pharma has to do better than this.
Stoppages of clinical trials are a normal part of the testing process, and show that patient safety is being taken seriously.
The phase 3 trials of the University of Oxford/AstraZeneca vaccine have been paused because one participant became unwell. But we don't know for sure if the illness was a reaction to the vaccine.
The Australian government is working with two major pharmaceutical companies to facilitate the local production and supply of two different COVID-19 vaccines – if they're proven to be effective.
Lisa Maree Wiliams/AAP
The federal government has secured two possible vaccine sources with a $1.7 billion supply and production agreement with two pharmaceutical companies.
The vaccine hasn't completed phase 3 trials, so we can't be sure it will be safe and effective for all. The Australian government's deal is contingent on these trials being successful.
The rush to be first.
Instead of a global response to the pandemic, we're seeing an outbreak of vaccine nationalism.
The experimental vaccine stimulates the creation of antibodies. Now we need to show that these effectively protect us from the coronavirus.
The furore over US pharmaceuticals giant Pfizer’s attempted takeover of UK rival AstraZeneca continues. AstraZeneca has now rejected Pfizer’s “final” offer, as it says the proposed deal “undervalues the…
Pfizer can’t stop moving.
Pfizer is like Woody Allen’s famous shark. It has to keep moving or it will die. And the drug company seems unable to keep moving by any means other than acquisitions. Its all-time best-selling drug, Lipitor…